Why India?   Clinical Research Industry      Europe      Asia      Latin America      United States   Clinical Trials   Clinical Data Management   Central Reference Lab   CLINICAL RESEARCH INDUSTRY   LATIN AMERICA     Latin America used to be viewed as a region with poor healthcare systems and below average investigators pool, which were below the Global standards. Gradually with the Governments’ support and change in the healthcare system, this view changed substantially. Now the systems comply with the GCP and ICH standards. The top markets for the clinical research industry in Latin America are Brazil, Mexico and Argentina, where there is high support for patient recruitment. Since most of the patients in these regions are below the lower income brackets, most often they find treatment through trials a more viable option. Based on a study conducted by Centre Watch, most of the sites in Latin America have gained experience and conduct approx 2 trials a year. The Government in this region now recognizes the potential of the industry and the benefits to countries by participating in clinical trials, thereby the region has implemented clear controlling processes and legislation, for making it a lucrative destination for clinical research. These regions have now mandated the need for authorization of clinical trials by ethics committees and regulatory authorities (approval spanning 2-4 months on an average). The market today can be estimated to grow ten fold in the next five years. This market not only has attracted the largest CRO's due to patient benefits but also has an impressive potential for pharma drugs. Since the market is growing, companies that begin to conduct trials in this region will also be positioned to benefit from increased investigator brand awareness with investigators prescribing products from sponsors of trials in which they participated.   > next

Privacy Policy     Disclaimer